PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
about
The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic DeathMetabotropic glutamate receptors as a new therapeutic target for malignant gliomasFibulin-4 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition via the PI3K/Akt/mTOR pathway.Antitumor activity of high-dose pulsatile gefitinib in non-small-cell lung cancer with acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors.Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cellsmicroRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma CellsGSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase SignalingsGab3 overexpression in human glioma mediates Akt activation and tumor cell proliferation.Overexpression of TELO2 decreases survival in human high-grade gliomas.Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft ModelsSynergistic antitumor activity of the combination of salubrinal and rapamycin against human cholangiocarcinoma cells.AKT/GSK3β Signaling in Glioblastoma.MicroRNA-137 inhibits growth of glioblastoma through EGFR suppression.Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Magnetic Resonance Imaging and Spectroscopy in Cancer Theranostic Imaging.Towards Targeting PI3K-Dependent Regulation of Gene Expression in Brain CancerCENPH Inhibits Rapamycin Sensitivity by Regulating GOLPH3-dependent mTOR Signaling Pathway in Colorectal Cancer.Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells.Rapamycin promotes differentiation increasing βIII-tubulin, NeuN, and NeuroD while suppressing nestin expression in glioblastoma cellsKaempferol induces autophagic cell death of hepatocellular carcinoma cells via activating AMPK signaling.The β-glucan from Lentinus edodes suppresses cell proliferation and promotes apoptosis in estrogen receptor positive breast cancers.Targeting cyclophilin-D by compound 19 protects neuronal cells from oxygen glucose deprivation/re-oxygenation.ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo.Autophagy inhibition sensitizes LY3023414-induced anti-glioma cell activity in vitro and in vivo.LEF1-AS1, a long-noncoding RNA, promotes malignancy in glioblastoma.The long non-coding RNA CRNDE acts as a ceRNA and promotes glioma malignancy by preventing miR-136-5p-mediated downregulation of Bcl-2 and Wnt2.5-Aminolevulinic Acid Guided Sampling of Glioblastoma Microenvironments Identifies Pro-Survival Signaling at Infiltrative Margins.Overexpression of CAPN2 promotes cell metastasis and proliferation via AKT/mTOR signaling in renal cell carcinoma.mTOR-Dependent Cell Proliferation in the Brain.L-Carnitine Attenuates Cardiac Dysfunction by Ischemic Insults Through Akt Signaling Pathway.The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma.The effects of PI3K-mediated signalling on glioblastoma cell behaviour.Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas.MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway.Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion.Activation of the mTOR signaling pathway in peritumoral tissues can cause glioma-associated seizures.EYA2 promotes lung cancer cell proliferation by downregulating the expression of PTEN.Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer.Metformin inhibits TGF-β1-induced epithelial-to-mesenchymal transition-like process and stem-like properties in GBM via AKT/mTOR/ZEB1 pathway.NF-κB Signalling in Glioblastoma.
P2860
Q28554467-F32CBF14-223C-42C7-9076-9357930A2361Q33591900-92DCA90D-8FD6-4D12-B419-0F3FD229C80CQ33598331-66F6CCEA-2024-4C76-8604-93BDF2F6CC1DQ33744196-FB236D36-0832-4CB0-8FF0-A3C3083ADBE8Q33798642-DCC5F216-7B37-42CF-BFDF-1383554D510FQ36050424-890EAED1-36B2-49BC-94F3-BA4CB2C230BCQ36105554-284E3F96-B47D-48C7-B32A-305D00A30A32Q36307539-38E8CCF9-4905-48AD-8351-04C822ECCA0CQ37564650-7063559C-DF52-4EEA-B9A4-11AEEE033EC2Q37615383-2E5B6087-612F-4615-A17B-A1907FA59197Q37709171-C3CE2752-650B-4D0E-A0F9-A7974D658D91Q37710163-654B7B11-E330-4593-90B3-6C889DDA7AE9Q37733071-53EA6461-6A3B-4E7E-BBCF-AFC2B8793B70Q38743138-0368F7FC-2096-4A41-96F1-087A737A928CQ38982546-A1B3B1A5-B34D-431F-847B-F3670A82F29EQ39337955-558A1A22-723F-4E6F-B97F-736618DD4182Q41440959-AB3C4932-55B2-4092-819C-71F4F63318E5Q42010694-9F3CF9DD-1894-48D9-834F-927BEF77DCCAQ42244908-6C2FAD47-EBE3-4A3B-AB13-8A21C504F63EQ45175810-3D34AC28-6160-4944-9EE1-6618BEE4F7CAQ45770844-2ACAFB1E-B9BA-4C2A-8649-0EA1CE38E43BQ45823361-0ECF6BA1-5151-4E63-9402-0F35971011A2Q47103348-96C097F4-1FAF-40D2-8082-34B0ED266122Q47106122-7B425DAE-92E3-4321-862B-58E9477DFE0CQ47114133-E610D99A-3E49-4C84-91B2-09DEA7BD6104Q47116860-2EDD1B10-E743-46CB-9F3C-C68F9B79DA29Q47134867-CACE7F50-FFA1-497F-87E7-0B16D21B4A25Q47143235-66ADC164-1A23-4C88-AD92-590A5E082FB3Q47231432-CA7D8B9A-0600-4B5A-89A3-76FB0E31AD43Q47705867-255E32B8-BA6A-4B96-908B-ADC9E0A06B57Q47868509-57864FFC-C344-44D0-AF69-4C610275C43EQ47945880-6D50E85E-26BD-4024-A372-8720EE2C7757Q48009516-EDE1CBC3-7FFC-4AF2-BD1B-FE2EF8AECEBFQ48089299-0B1D783F-2661-44F6-8458-1D6C4ED478AEQ48161755-CD4DF53D-23D3-450B-819B-F0A717F420E1Q48504763-633F5280-BFE2-41AB-964B-502E80929641Q49497954-0B85D474-6B9D-4001-A8F6-227624F41550Q49952154-D130449A-BB1E-4D14-A2C7-A88AD855E0E6Q50327413-337B3842-B392-4EC4-94A4-A397A91C8BACQ52091959-6C9BEEC8-6F58-427F-B7E9-B4FB91FA6864
P2860
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
@ast
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
@en
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
@nl
type
label
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
@ast
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
@en
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
@nl
prefLabel
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
@ast
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
@en
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
@en
P2093
Changjing Wu
Enhua Wang
Liang Wang
Nianci Chen
Xiaoman Li
P2860
P3181
P356
10.18632/ONCOTARGET.7961
P407
P5008
P577
2016-03-07T00:00:00Z
2016-05-31T00:00:00Z